Description: Recommendation to measure the risk for the components of combination Life/LTC products.

Description: The hybrid Life/LTC and Life / Chronic Illness market is an exciting market that is in its relative infancy. There are many new companies that have just entered, or are considering entering, the hybrid market. Hybrid sales have grown tremendously over the past decade and are still going strong, with annual premium revenue estimated to be above $4 billion per year. The young issue ages for these products, relative to when LTC benefits are paid, means that the claim experience in the industry for these products is still very limited. Additionally, there are many moving parts to these products that present correlated risks and assumptions. The new entrants to the market, limited experience, and the interactions of risks create an environment equipped for vibrant discussions on the product structure, risks, assumptions, and considerations for modeling these hybrid products. The presenters would provide insight into each of these topics through a conceptual discussion, supported by observational data from case study projections and sensitivities.